Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials

OBJECTIVE: The number of individuals diagnosed with type 2 diabetes mellitus is expected to rise disproportionately in Hispanic/Latino populations. We therefore aimed to assess the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin specifically in Hispanic/Latino patients with t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Davidson, Jaime A, Lajara, Rosemarie, Aguilar, Richard B, Mattheus, Michaela, Woerle, Hans-Juergen, von Eynatten, Maximilian
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2014
Assuntos:
Perspectives in Diabetes
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4212575/
https://ncbi.nlm.nih.gov/pubmed/25452864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2014-000020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados